Enhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
Enhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
APOL1 and Chronic Kidney Disease: New Findings in African Populations
APOL1 and Chronic Kidney Disease: New Findings in African Populations
Diagnosing IgAN: The Importance of Early and Accurate Identification
Diagnosing IgAN: The Importance of Early and Accurate Identification
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Achieving Optimal Outcomes in Lupus Nephritis: Key Updates from the 2024 ACR Guidelines
Achieving Optimal Outcomes in Lupus Nephritis: Key Updates from the 2024 ACR Guidelines
IgAN Explained: Key Differences from Other Kidney Conditions
IgAN Explained: Key Differences from Other Kidney Conditions
IgAN Insights: The Potential Role of the Complement System in Disease Progression
IgAN Insights: The Potential Role of the Complement System in Disease Progression
Identifying Patients at High-Risk for IgAN Progression: Key Factors to Know
Identifying Patients at High-Risk for IgAN Progression: Key Factors to Know
The Pathogenesis of Complement 3 Glomerulopathy (C3G)
The Pathogenesis of Complement 3 Glomerulopathy (C3G)
The Endothelin System and IgAN: Emerging Evidence
The Endothelin System and IgAN: Emerging Evidence
IgAN Insights: The Impact of Proteinuria
IgAN Insights: The Impact of Proteinuria